Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutamatergic dysfunction in Schizophrenia
Andreas O. Kruse, Juan Bustillo
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Advancing cell therapy for neurodegenerative diseases
Sally Temple
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 512-529
Open Access | Times Cited: 89
The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
Daniela L. Uliana, João Roberto Lisboa, Felipe V. Gomes, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116298-116298
Closed Access | Times Cited: 13
Functional crosstalk of the glycine transporter GlyT1 and NMDA receptors
Dolores Piniella, Francisco Zafra
Neuropharmacology (2023) Vol. 232, pp. 109514-109514
Open Access | Times Cited: 19
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
Samantha E. Yohn, P.D. Harvey, Stephen K. Brannan, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Using a comprehensive atlas and predictive models to reveal the complexity and evolution of brain-active regulatory elements
Henry Pratt, Gregory Andrews, Nicole Shedd, et al.
Science Advances (2024) Vol. 10, Iss. 21
Open Access | Times Cited: 5
Ketamine Infusion for Complex Regional Pain Syndrome Treatment: A Narrative Review
Alan D. Kaye, Brynne E Tynes, Coplen D. Johnson, et al.
Current Pain and Headache Reports (2025) Vol. 29, Iss. 1
Closed Access
Investigating the Interplay Between the Nrf2/Keap1/HO-1/SIRT-1 Pathway and the p75NTR/PI3K/Akt/MAPK Cascade in Neurological Disorders: Mechanistic Insights and Therapeutic Innovations
R Mukherjee, R.S. Rana, Sidharth Mehan, et al.
Molecular Neurobiology (2025)
Closed Access
Changes in glutamate levels in anterior cingulate cortex following 16 weeks of antipsychotic treatment in antipsychotic-naïve first-episode psychosis patients
Jose O. Maximo, Eric Nelson, Nina V. Kraguljac, et al.
Psychological Medicine (2025) Vol. 55
Closed Access
Optical Coherence Tomography in Patients with Schizophrenia: An Exploratory Study
Shashidhara Munivenkatappa, Pratyusha Ganne, Muralidhar Parri, et al.
Psychiatry Research Neuroimaging (2025) Vol. 349, pp. 111972-111972
Closed Access
IUPHAR Review - Novel therapeutic targets for schizophrenia treatment: a translational perspective
Veronica Begni, Alessia Marchesin, Marco Andrea Riva
Pharmacological Research (2025), pp. 107690-107690
Open Access
The SIK1/CRTC2/CREB1 and TWIST1/PI3K/Akt/GSK3β signaling pathways mediated by microRNA-25-3p are altered in the schizophrenic rat brain
Bo Pan, Xiaoli Zhu, Bing Han, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Inferring causal cell types of human diseases and risk variants from candidate regulatory elements
Artem Kim, Zixuan Zhang, Come Legros, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Adrenalectomy exacerbates stress-induced impairment in fear discrimination: A causal role for kynurenic acid?
Alex Klausing, Tsutomu Fukuwatari, Nicole E. DeAngeli, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116350-116350
Closed Access | Times Cited: 3
mGluR5 positive allosteric modulation prevents MK-801 induced increases in extracellular glutamate in the rat medial prefrontal cortex
Amber L. LaCrosse, Christina E. May, William C. Griffin, et al.
Neuroscience (2024) Vol. 555, pp. 83-91
Closed Access | Times Cited: 3
Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex
Lejia Fan, Liangbing Liang, Yujue Wang, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 5, pp. 845-853
Open Access | Times Cited: 8
Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia
Andrea de Bartolomeis, Mariateresa Ciccarelli, Giuseppe De Simone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5945-5945
Open Access | Times Cited: 7
A functional schizophrenia-associated genetic variant near the TSNARE1 and ADGRB1 genes
Marah H. Wahbeh, Rachel J. Boyd, Christian Yovo, et al.
Human Genetics and Genomics Advances (2024) Vol. 5, Iss. 3, pp. 100303-100303
Open Access | Times Cited: 2
PET‐MRI Applications and Future Prospects in Psychiatry
Nicole R. Zürcher, Jingyuan E. Chen, Hsiao‐Ying Wey
Journal of Magnetic Resonance Imaging (2024)
Closed Access | Times Cited: 2
Dopaminergic Modulation of Prefrontal Cortex Inhibition
Danila Di Domenico, Lisa Mapelli
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1276-1276
Open Access | Times Cited: 6
Ketamine, an Old–New Drug: Uses and Abuses
Katarina Savić Vujović, Ana Jotić, Branislava Medić, et al.
Pharmaceuticals (2023) Vol. 17, Iss. 1, pp. 16-16
Open Access | Times Cited: 6
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
Licia Vellucci, Mariateresa Ciccarelli, Elisabetta Filomena Buonaguro, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1220-1220
Open Access | Times Cited: 5
A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine
Kouji Fukuyama, Eishi Motomura, Motohiro Okada
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1288-1288
Open Access | Times Cited: 5
The potential role of miRNAs in the pathogenesis of schizophrenia – A focus on signaling pathways interplay
Mohamed Bakr Zaki, Ahmed I. Abulsoud, Alaa Ashraf, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155102-155102
Closed Access | Times Cited: 1
Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia
Zijin Feng, Zhijing Hu, Lei Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
NMDA glutamate receptor antagonist MK‐801 induces proteome changes in adult human brain slices which are partially counteracted by haloperidol and clozapine
Valéria de Almeida, Niele Dias Mendes, Giuliana S. Zuccoli, et al.
Journal of Neurochemistry (2024) Vol. 168, Iss. 3, pp. 238-250
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top